戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ist, GR144053F, inhibited platelet-dependent APC resistance.
2 ln), that has been found in association with APC resistance.
3 or pharmacologic interventions to counteract APC resistance.
4 sent in a first degree relative who also had APC resistance.
5 ffects of fibrinogen and its gamma' chain on APC resistance.
6 ew insights into the molecular mechanisms of APC resistance.
7  a new way of measuring activated protein C (APC) resistance.
8 ents with a hypercoagulable state related to APC resistance (18 women, five men; average age, 44.5 ye
9                   In the general population, APC resistance and factor V Leiden were important VTE ri
10                                              APC resistance and increased thrombotic risk are due to
11                                Patients with APC resistance and stroke appear to differ from the gene
12 s study, we have measured platelet-dependent APC resistance and the effect of aspirin and a platelet
13            It also supports the concept that APC resistance and venous thrombosis can result from a v
14 FVNara) associated with activated protein C (APC) resistance and a severe thrombotic phenotype in a y
15  Leiden, HR2 haplotype, activated protein C (APC) resistance, and plasma factor V antigen in 335 part
16                     Thus, the success of the APC-resistance assay is based on the fortuitous activati
17 s assessed to be hyperhomocysteinemic showed APC resistance in a clot-based assay.
18                        We observed increased APC resistance in carriers of fibrinogen gamma gene (FGG
19 atients with venous thrombosis and confirmed APC resistance in the absence of the common Gln506 mutat
20 ntrifugation at 77,000g for 1 hour abolished APC resistance indicating that the phenotype is associat
21 ic inactivation of factors Va and VIIIa, and APC resistance is often caused by factor V Leiden.
22                                              APC resistance measured after predilution with factor V-
23                                              aPC resistance of factor (f)V due to the R506Q Leiden mu
24                         Activated protein C (APC) resistance, often associated with the factor V (FV)
25                       The platelet-dependent APC resistance phenotype was also observed when endogeno
26 ion and modulation of the platelet-dependent APC resistance phenotype.
27                                          The APC resistance ratio values (ratio of activated partial
28 ase treatment of factor V did not change the APC resistance ratio.
29 Va was cleaved by APC at R506 and gave a low APC-resistance ratio similar to Q506-rFVa in clotting as
30 reas unactivated Q306-rFV gave a near-normal APC-resistance ratio.
31  including the presence of borderline or low APC resistance ratios among patients who lack the R506Q
32 account for some of the known variability in APC resistance ratios, including the presence of borderl
33  activated partial thromboplastin time-based APC resistance ratios.
34 up, a second-generation activated protein C (APC)-resistance screening test with genetic confirmation
35                    Other potential causes of APC resistance, such as a mutation at the Arg679 site an
36 generation preparations have higher acquired APC resistance than users of second-generation products.
37                                              APC resistance was not observed in the presence of phosp
38                                              APC resistance was observed in the presence of platelet-
39   In platelet rich plasma (PRP), progressive APC resistance was observed with increasing platelet act
40  patient's plasma and found to induce severe APC resistance when added to normal plasma and to factor
41  to an indirect effect on platelet-dependent APC resistance with reduced platelet retention within a

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。